HSV-1 Therapy of Malignant Tumors in Mice

Miller, Cathie G.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Postdoctoral Individual National Research Service Award (F32)
• Project #: 1F32CA077903-01A1
• Application #: 2775251
• Study Section: Special Emphasis Panel (ZRG2-SSS-1 (01))
• Program Officer: Lohrey, Nancy
• Project Start: 1999-10-01
• Budget Start: 1999-10-01
• Budget End: 2000-07-31
• Support Year: 1
• Fiscal Year: 1999

Institution

• Name: University of Pennsylvania
• Department: Microbiology/Immun/Virology
• Type: Schools of Medicine
• DUNS #: 042250712
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19104

Publications

Miller, C G; Krummenacher, C; Eisenberg, R J et al. (2001) Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1. Mol Ther 3:160-8

Poptani, H; Duvvuri, U; Miller, C G et al. (2001) T1rho imaging of murine brain tumors at 4 T. Acad Radiol 8:42-7

Miller, C G; Fraser, N W (2000) Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model. Cancer Res 60:5714-22